PolyCore Therapeutics LLC is a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders.

PolyCore Therapeutics LLC is a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders. PolyCore is current conducting preclinical studies for its lead compound, PCT-3012, a novel G protein-biased agonist of the D3 receptor, for treatment of Parkinson?s motor symptoms and dyskinesia in patients with early- to mid-stage Parkinson’s Disease.

Sector: Healthcare

Sub Sector: Pharma

Industry: Biotechnology

Status: Active

County: Philadelphia